Crosby Health builds a proprietary AI called Apollo to automate administrative tasks in healthcare. Apollo is an advanced clinical language model (LLM) for medical reasoning that analyzes unstructured clinical documentation. The platform automates clinical appeals end-to-end — generating initial appeals, submitting them, and tracking results — and also supports AI medical coding, chart reviews, and denial management. Crosby positions Apollo as a revenue-cycle expert to improve denial recovery rates, tracking intelligence, and overall revenue cycle efficiency for providers. Led by CEO Rishi Gowda, the company intends to use new capital to expand development efforts and broaden business reach. Crosby Health raised $2.2M in a pre-seed round to advance product development and market growth.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

May 2024